Circulating cytokines and soluble CD23, CD26 and CD30 in ANCA-associated vasculitides

Clinical and Experimental Rheumatology

Volumn 18, Issue 4, 2000, Pages 457-463

  Schonermarck, U ^a   Csernok, E ^a   Trabandt, A ^a   Hansen, H ^a   Gross, W L ^a  

^a Rheumaklinik Bad Bramstedt   (Germany)

Author keywords

ANCA cytokine; Soluble CD26; Soluble CD30; Vasculitis

Indexed keywords

CD23 ANTIGEN; CD30 ANTIGEN; CYTOKINE; DIPEPTIDYL PEPTIDASE IV; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; AGED; ARTICLE; B LYMPHOCYTE ACTIVATION; CHURG STRAUSS SYNDROME; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMORAL IMMUNITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REMISSION; SYSTEMIC VASCULITIS; T LYMPHOCYTE ACTIVATION; WEGENER GRANULOMATOSIS;

ADULT; AGED; ANTIGENS, CD; ANTIGENS, CD26; ANTIGENS, CD30; BIOLOGICAL MARKERS; CHURG-STRAUSS SYNDROME; CYTOKINES; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-13; INTERLEUKIN-4; INTERLEUKIN-5; MALE; MIDDLE AGED; RECEPTORS, IGE; SOLUBILITY; TH1 CELLS; TH2 CELLS; WEGENER GRANULOMATOSIS;

EID: 0033866586     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Anti-neutrophil cytoplasmic autoantibodies, auto-antigens, and systemic vasculitis
2. Elevated serum levels of soluble interleukin-2 receptor in patients with Wegener's granulomatosis. Association with disease activity
3. Pathogenesis of Wegener's granulomatosis
4. Churg-Strauss syndrome. Serum markers of lymphocyte activation and endothelial damage
5. Pleiotropic biologic functions of CD30/CD30L Does it contribute to negative selection in thymus?
6. Circulating levels of soluble CD30, a marker of cells producing Th2-type cytokines, are increased in patients with systemic lupus erythematosus and correlate with disease activity
7. High levels of the soluble form of CD30 molecule in rheumatoid arthritis (RA) are expression of CD30+ T cell involvement in the inflamed joints
8. High plasma levels of i the soluble form of CD30 activation molecule reflect disease activity in patients with Wegener's granulomatosis
9. Serum levels of soluble CD30 are increased in ulcerative colitis (UC) but not in Crohn's disease
10. Interleukin-12 enhances CD26 expression and dipeptidyl peptidase IV function on human activated lymphocytes
11. Comparative study of CD26 as a Th1-like and CD30 as a potential Th2-like operational marker in leprosy
12. Cell surface characterization of T lymphocytes and allergen-specific T cell clones: Correlation of CD26 expression with T(H1) subsets
13. Serum high molecular weight dipeptidyl peptidase IV (CD26) is similar to a novel antigen DPPT-L released from activated T cells
14. CD23 and B cell activation
15. Soluble CD23 levels in the serum of patients with primary Sjogren's syndrome and systemic lupus erythematosus
16. Increased production of soluble CD23 in rheumatoid arthritis, and its regulation by interleukin-4
17. Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia
18. An assessment of peripheral immunity in patients with sarcoidosis using measurements of serum vitamin D3; cytokines and soluble CD23
19. Serum sCD23 in patients with lepromatous and tuberculoid leprosy
20. Serum soluble CD23 levels and CD23 expression on peripheral blood mononuclear cells in juvenile chronic arthritis
21. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis
22. Nomenclature of systemic vasculitides: Proposal of an international consensus conference
23. Influence of disease manifestation and antineutrophil cytoplasmic antibody titer on the response to pulse cyclophosphamide therapy in patients with Wegener's granulomatosis
24. Diagnostic value of standardized assays for antineutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Projects for ANCA Assay Standardization
25. Elevated interleukin-10 levels in patients with rheumatoid arthritis
26. Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis
27. Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus
28. CD30 expression does not discriminate between human Th1- and Th2-type T cells
29. Cytokine profile in Wegener's granulomatosis: Predominance of a type 1 (Th1) in the granulomatous inflammation
30. Alterations in plasma dipeptidyl peptidase IV enzyme activity in depression and schizophrenia: Effects of antidepressant and antipsychotic drugs
31. Interleukin-12-dependent activation of human lymphocyte subsets